These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37343908)

  • 21. 3-Bromopyruvate regulates the status of glycolysis and BCNU sensitivity in human hepatocellular carcinoma cells.
    Sun X; Sun G; Huang Y; Hao Y; Tang X; Zhang N; Zhao L; Zhong R; Peng Y
    Biochem Pharmacol; 2020 Jul; 177():113988. PubMed ID: 32330495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-acetyl-galactosamine modified metal-organic frameworks to inhibit the growth and pulmonary metastasis of liver cancer stem cells through targeted chemotherapy and starvation therapy.
    Hu J; Hu J; Wu W; Qin Y; Fu J; Zhou J; Liu C; Yin J
    Acta Biomater; 2022 Oct; 151():588-599. PubMed ID: 36002126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanomedicines for Reactive Oxygen Species Mediated Approach: An Emerging Paradigm for Cancer Treatment.
    Kwon S; Ko H; You DG; Kataoka K; Park JH
    Acc Chem Res; 2019 Jul; 52(7):1771-1782. PubMed ID: 31241894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tp53-induced glycolysis and apoptosis regulator (TIGAR) protects glioma cells from starvation-induced cell death by up-regulating respiration and improving cellular redox homeostasis.
    Wanka C; Steinbach JP; Rieger J
    J Biol Chem; 2012 Sep; 287(40):33436-46. PubMed ID: 22887998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver-targeted Nano-MitoPBN normalizes glucose metabolism by improving mitochondrial redox balance.
    Wu M; Liao L; Jiang L; Zhang C; Gao H; Qiao L; Liu S; Shi D
    Biomaterials; 2019 Nov; 222():119457. PubMed ID: 31476661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel roles of folic acid as redox regulator: Modulation of reactive oxygen species sinker protein expression and maintenance of mitochondrial redox homeostasis on hepatocellular carcinoma.
    Lai KG; Chen CF; Ho CT; Liu JJ; Liu TZ; Chern CL
    Tumour Biol; 2017 Jun; 39(6):1010428317702649. PubMed ID: 28639913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Boosting the Ferroptotic Antitumor Efficacy via Site-Specific Amplification of Tailored Lipid Peroxidation.
    An Y; Zhu J; Liu F; Deng J; Meng X; Liu G; Wu H; Fan A; Wang Z; Zhao Y
    ACS Appl Mater Interfaces; 2019 Aug; 11(33):29655-29666. PubMed ID: 31359759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Redox-responsive star-shaped magnetic micelles with active-targeted and magnetic-guided functions for cancer therapy.
    Tang Z; Zhang L; Wang Y; Li D; Zhong Z; Zhou S
    Acta Biomater; 2016 Sep; 42():232-246. PubMed ID: 27373437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanotherapeutics interfere with cellular redox homeostasis for highly improved photodynamic therapy.
    Cheng Q; Yu W; Ye J; Liu M; Liu W; Zhang C; Zhang C; Feng J; Zhang XZ
    Biomaterials; 2019 Dec; 224():119500. PubMed ID: 31557591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TCA-phospholipid-glycolysis targeted triple therapy effectively suppresses ATP production and tumor growth in glioblastoma.
    Yang S; Zhao J; Cui X; Zhan Q; Yi K; Wang Q; Xiao M; Tan Y; Hong B; Fang C; Kang C
    Theranostics; 2022; 12(16):7032-7050. PubMed ID: 36276638
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibitory effects of 3-bromopyruvate in human nasopharyngeal carcinoma cells.
    Zou X; Zhang M; Sun Y; Zhao S; Wei Y; Zhang X; Jiang C; Liu H
    Oncol Rep; 2015 Oct; 34(4):1895-904. PubMed ID: 26239511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HBx regulates fatty acid oxidation to promote hepatocellular carcinoma survival during metabolic stress.
    Wang MD; Wu H; Huang S; Zhang HL; Qin CJ; Zhao LH; Fu GB; Zhou X; Wang XM; Tang L; Wen W; Yang W; Tang SH; Cao D; Guo LN; Zeng M; Wu MC; Yan HX; Wang HY
    Oncotarget; 2016 Feb; 7(6):6711-26. PubMed ID: 26744319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Manipulation of tumor metabolism for therapeutic approaches: ovarian cancer-derived cell lines as a model system.
    Goetze K; Fabian CG; Siebers A; Binz L; Faber D; Indraccolo S; Nardo G; Sattler UG; Mueller-Klieser W
    Cell Oncol (Dordr); 2015 Oct; 38(5):377-85. PubMed ID: 26288178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ATP-triggered mitochondrial cascade reactions for cancer therapy with nanoscale zeolitic imidazole framework-90.
    Pan W; Cui B; Wang K; Shi M; Lu F; Li N; Tang B
    Theranostics; 2021; 11(16):7869-7878. PubMed ID: 34335969
    [No Abstract]   [Full Text] [Related]  

  • 35. Redox mechanism of levobupivacaine cytostatic effect on human prostate cancer cells.
    Jose C; Hebert-Chatelain E; Dias Amoedo N; Roche E; Obre E; Lacombe D; Rezvani HR; Pourquier P; Nouette-Gaulain K; Rossignol R
    Redox Biol; 2018 Sep; 18():33-42. PubMed ID: 29935387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted reversal and phosphorescence lifetime imaging of cancer cell metabolism via a theranostic rhenium(I)-DCA conjugate.
    Yang J; Cao Q; Zhang H; Hao L; Zhou D; Gan Z; Li Z; Tong YX; Ji LN; Mao ZW
    Biomaterials; 2018 Sep; 176():94-105. PubMed ID: 29870900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Metabolic Multistage Glutathione Depletion Used for Tumor-Specific Chemodynamic Therapy.
    Huang Y; Wu S; Zhang L; Deng Q; Ren J; Qu X
    ACS Nano; 2022 Mar; 16(3):4228-4238. PubMed ID: 35213138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radioresistant Cervical Cancers Are Sensitive to Inhibition of Glycolysis and Redox Metabolism.
    Rashmi R; Huang X; Floberg JM; Elhammali AE; McCormick ML; Patti GJ; Spitz DR; Schwarz JK
    Cancer Res; 2018 Mar; 78(6):1392-1403. PubMed ID: 29339540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrial metabolism-mediated redox regulation in cancer progression.
    Boese AC; Kang S
    Redox Biol; 2021 Jun; 42():101870. PubMed ID: 33509708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicomponent metal-organic framework nanocomposites for tumor-responsive synergistic therapy.
    Hur W; Park Y; Seo E; Son SE; Kim S; Seo H; Seong GH
    J Colloid Interface Sci; 2023 Sep; 645():663-675. PubMed ID: 37167915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.